Skip to main content
Clinical Trials/NCT01953978
NCT01953978CompletedPhase 4

The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen as Adjuvant, Postoperative Pain After Herniated Disc Surgery

Rigshospitalet, Denmark1 site in 1 country160 target enrollmentStarted: December 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
160
Locations
1
Primary Endpoint
Painscore during mobilization

Study Overview

Brief Summary

The analgesic effect of dexamethasone is not well described, but studies have shown that dexamethasone can be a safe part of a multimodal analgesic strategy after surgery. Our purpose is to investigate if dexamethasone in combination with paracetamol and ibuprofen has an increased analgesic effect compared to paracetamol and ibuprofen alone, on postoperative pain after spine surgery. Our hypothesis is that dexamethasone can reduce postoperative pain and reduce opioidconsumption and side effects compared to placebo.

Detailed Description

The analgesic effect of dexamethasone is not well described, but studies have shown that an intermediate dosis of dexamethasone (0.11-0.2 mg/kg) can be a safe part of a multimodal analgesic strategy after surgery. Dexamethasone has an opioid-sparing effect and reduces pain during rest and mobilisation. Our purpose is to investigate if dexamethasone in combination with paracetamol and ibuprofen has an increased analgesic effect compared to paracetamol and ibuprofen alone, on postoperative pain after herniated disk surgery. Our hypothesis is that dexamethasone can reduce postoperative pain and reduce opioidconsumption and side effects compared to placebo.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing lumbar disc surgery in general anaesthesia.
  • Patients who have given their written consent to participate and understand the contents of the protocol.
  • BMI > 18 og <
  • Fertile women need a negative HCG urine test.

Exclusion Criteria

  • Patients who cannot cooperate to the study.
  • Patients who do not speak and/or understand Danish.
  • Fertile women with a positive HCG urine test.
  • Allergy to the drugs used in the trial.
  • Alcohol or medicine abuse, assessed by investigator.
  • Patients who have had spine surgery before.
  • Daily use of strong opioids (morphine, ketobemidone, oxynorm, methadone, fentanyl)
  • Daily oral steroid treatment.

Arms & Interventions

Dexamethasone

Active Comparator
  • Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Dexamethasone (Drug)

Dexamethasone

Active Comparator
  • Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Morphine (Drug)

Dexamethasone

Active Comparator
  • Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Zofran (Drug)

Dexamethasone

Active Comparator
  • Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Paracetamol (Drug)

Dexamethasone

Active Comparator
  • Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Ibuprofen (Drug)

Placebo

Placebo Comparator
  • Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Placebo (Other)

Placebo

Placebo Comparator
  • Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Morphine (Drug)

Placebo

Placebo Comparator
  • Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Zofran (Drug)

Placebo

Placebo Comparator
  • Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Paracetamol (Drug)

Placebo

Placebo Comparator
  • Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
  • Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
  • Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
  • Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intervention: Ibuprofen (Drug)

Outcomes

Primary Outcomes

Painscore during mobilization

Time Frame: 2-24 hours after extubation time.

Painscore during active mobilization (VAS scale) defined by a standarized movement from recumbent position to sitting on the bedside at time 2, 4, 8, 12 and 24 hours, calculated as area under curve (AUC) from 2-24 hours after extubation time.

Secondary Outcomes

  • Morphine consumption(0-24 hours after extubation time.)
  • Incidence of vomiting(0-2, 2-4, 4-8, 8-12, 12-24 and 24-48 hours after extubation time.)
  • Degree of sedation(2, 4, 8, 12, 24 and 48 hours after extubation time.)
  • Painscore during rest(2-24 hours after extubation time)
  • Painscore during rest and mobilization(48 hours after extubation time)
  • Zofran consumption(0-24 and 24-48 hours after extubation time.)
  • Degree of nausea(2, 4, 8, 12, 24 and 48 hours after extubation time)
  • Quality of sleep(24 hours after extubation time.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rikke Vibeke Nielsen, MD

MD

Glostrup University Hospital, Copenhagen

Study Sites (1)

Loading locations...

Similar Trials